Publications by authors named "Jason Agulnik"

Claim this Profile
T
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE).
William J Phillips, Luna Jia Zhan, Deepro Chowdhury, Jeniszka Gill, Alexander Sun, Jason Agulnik

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840].
William J Phillips, Luna Jia Zhan, Deepro Chowdhury, Jeniszka Gill, Alexander Sun, Jason Agulnik

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC.
Barbara Melosky, Quincy S C Chu, Rosalyn A Juergens, Stephanie Snow, Normand Blais, Jason Agulnik

Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?
Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, Andrew Meng, Maxime Têtu, Jason Agulnik

Ann Thorac Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Surveillance for Patients With Head and Neck Cancer.
Naif Fnais, Francisco Laxague, Marco A Mascarella, Raisa Chowdhury, Hedi Zhao, Jason Agulnik

JAMA Otolaryngol Head Neck Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
David Spillane, Carmela Pepe, Goulnar Kasymjanova, Diane Cruiziat, Sara Cohen, Jason Agulnik

Curr Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Screening in Family Members and Peers of Patients With Lung Cancer: Protocol for a Prospective Cohort Study.
Isabelle Pitrou, Adriano Petrangelo, Charlotte Besson, Carmela Pepe, Annika Helen Waschke, Jason Agulnik

JMIR Res Protoc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study).
Ramy Samaha, Rola El Sayed, Raafat Alameddine, Marie Florescu, Mustapha Tehfe, Jason Agulnik

Curr Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models and Biomarkers for Local Response Prediction in Early-Stage and Oligometastatic Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Using Machine Learning.
Gemini Ramasamy, Thierry Muanza, Goulnar Kasymjanova, Jason Agulnik

Cureus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Differences in Immunotherapy Outcomes of Patients with Advanced Non-Small Cell Lung Cancer.
Sara Frida Cohen, Diane Cruiziat, Jeremy Naimer, Victor Cohen, Goulnar Kasymjanova, Jason Agulnik

Curr Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in KRAS-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study.
Samir H Barghout, Luna Jia Zhan, Starvroula Raptis, Faisal Al-Agha, Niki Esfahanian, Jason Agulnik

Lung Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Yohann Pilon, Merav Rokah, Joseph Seitlinger, Boris Sepesi, Roni F Rayes, Jason Agulnik

Clin Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective.
Jason Agulnik, Goulnar Kasymjanova, Carmela Pepe, Jennifer Friedmann, David Small

Curr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Lung cancer in Nunavik: How are we doing? A retrospective matched cohort study.
Yue Chen, Sarah MacIsaac, Matthew Young, Marlene Ahodakin, Luke Wan Jeagal, Jason Agulnik

CMAJ· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors.
Rachel Bierbrier, Kathleen D'Aguanno, Goulnar Kasymjanova, Sohie Dell'Aniello, Jason Agulnik

J Am Acad Dermatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center.
Goulnar Kasymjanova, Angelo Rizzolo, Carmela Pepe, Jennifer E Friedmann, David Small, Jason S Agulnik

Curr Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
Doreen A Ezeife, Eldon Spackman, Rosalyn A Juergens, Janessa J Laskin, Jason S Agulnik

Ther Adv Med Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC).
Jason S Agulnik, Andreas I Papadakis, Carmela Pepe, Lama Sakr, David Small

Curr Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec.
Jason S Agulnik, Goulnar Kasymjanova, Carmela Pepe, Manjusha Hurry, Ryan N Walton

Curr Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review.
Goulnar Kasymjanova, Aksa Anwar, Victor Cohen, Khalil Sultanem, Carmela Pepe, Jason S Agulnik

Curr Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study.
Antoine Desilets, Félix Blanc-Durand, Sally Lau, Taiki Hakozaki, Rui Kitadai, Jason Agulnik

Eur J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition.
Mathilde Couëtoux du Tertre, Maud Marques, Suzan McNamara, Karen Gambaro, Cyrla Hoffert, Jason Agulnik

Clin Proteomics· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes.
Mathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay, Nicole Bouchard, Razvan Diaconescu, Jason Agulnik

Mol Cancer Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility study.
Goulnar Kasymjanova, Anh-Thi Tran, Victor Cohen, Carmela Pepe, Lama Sakr, Jason Scott Agulnik

J Integr Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.
Léon C van Kempen, Hangjun Wang, Maria Leonor Aguirre, Alan Spatz, Goulnar Kasymjanova, Jason Agulnik

J Thorac Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis